{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:28:17Z","timestamp":1759336097060,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.neuint.2022.105404","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:54:06Z","timestamp":1657947246000},"page":"105404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Chronic treatment with enhancer drugs modifies the gene expression of selected parameters related to brain plasticity in rats under stress conditions"],"prefix":"10.1016","volume":"159","author":[{"given":"K.","family":"Hrivikova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zelena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Graban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Puhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Miklya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Balazsfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jezova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2022.105404_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12264-019-00422-4","article-title":"Ketamine alleviates fear generalization through GluN2B-BDNF signaling in mice","volume":"36","author":"Asim","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuint.2022.105404_bib2","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2147\/NDT.S59107","article-title":"EMSAM (deprenyl patch): how a promising antidepressant was underutilized","volume":"10","author":"Asnis","year":"2014","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuint.2022.105404_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0306-4522(95)00084-V","article-title":"Stress-induced changes in messenger RNA levels of N-methyl-D-aspartate and AMPA receptor subunits in selected regions of the rat hippocampus and hypothalamus","volume":"66","author":"Bartanusz","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2022.105404_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fpsyt.2020.00501","article-title":"Reducing allostatic load in depression and anxiety disorders: physical activity and yoga practice as add-on therapies","volume":"11","author":"D'Alessio","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuint.2022.105404_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2007.06.046","article-title":"Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine","volume":"573","author":"Davidson","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105404_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1167\/iovs.03-0285","article-title":"Ischemia-induced changes of AMPA-type glutamate receptor subunit expression pattern in the rat retina: a real-time quantitative PCR study","volume":"45","author":"Dijk","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuint.2022.105404_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136194","article-title":"Trophic factors as potential therapies for treatment of major mental disorders","volume":"764","author":"Dremencov","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2022.105404_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1012658222954","article-title":"Altered function of peripheral organ systems in rats exposed to chronic mild stress model of depression","volume":"21","author":"Duncko","year":"2001","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105404_bib9","first-page":"606","article-title":"Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: involvement of CREB\/BDNF and Akt\/GSK3 signal pathways","volume":"23","author":"Feizipour","year":"2020","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.neuint.2022.105404_bib10","first-page":"709","article-title":"Increased gene expression of selected vesicular and glial glutamate transporters in the frontal cortex in rats exposed to voluntary wheel running","volume":"68","author":"Graban","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105404_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108630","article-title":"Genetic manipulations of AMPA glutamate receptors in hippocampal synaptic plasticity","volume":"194","author":"Gugustea","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2022.105404_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10571-009-9458-3","article-title":"Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo","volume":"30","author":"Gy\u00e1rf\u00e1s","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105404_bib13","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.neuron.2021.07.015","article-title":"The continued need for animals to advance brain research","volume":"109","author":"Homberg","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105404_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10571-017-0528-7","article-title":"Contribution of vesicular glutamate transporters to stress response and related psychopathologies: studies in VGluT3 knockout mice","volume":"38","author":"Horv\u00e1th","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105404_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnbeh.2017.00075","article-title":"Selegiline ameliorates depression-like behavior in mice lacking the cd157\/BST1 gene, a risk factor for Parkinson's disease","volume":"11","author":"Kasai","year":"2017","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neuint.2022.105404_bib16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/cells9041026","article-title":"Stress-induced morphological, cellular and molecular changes in the brain-lessons learned from the chronic mild stress model of depression","volume":"9","author":"Khan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2022.105404_bib17","first-page":"1","article-title":"Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition","volume":"328","author":"Knoll","year":"1994","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neuint.2022.105404_bib18","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/0024-3205(96)00204-4","article-title":"Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain","volume":"58","author":"Knoll","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2022.105404_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lfs.2016.10.023","article-title":"Longevity study with low doses of selegiline\/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP)","volume":"167","author":"Knoll","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2022.105404_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112290","article-title":"Synthetic enhancer compounds, besides acting on biogenic amine system, influence the glutamate transmission and stress response","volume":"378","author":"Knoll","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neuint.2022.105404_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085924","article-title":"Binding of Y-P30 to syndecan 2\/3 regulates the nuclear localization of CASK","volume":"9","author":"Landgraf","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2022.105404_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0306-4530(02)00062-8","article-title":"Voluntary wheel running modulates glutamate receptor subunit gene expression and stress hormone release in Lewis rats","volume":"28","author":"Makatsori","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuint.2022.105404_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0024-3205(94)00620-2","article-title":"Deprenyl reduces serum prolactin concentrations in rats","volume":"54","author":"MohanKumar","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2022.105404_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1007062109386","article-title":"Gene expression of two glutamate receptor subunits in response to repeated stress exposure in rat hippocampus","volume":"20","author":"Schwendt","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105404_bib25","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/S0024-3205(03)00191-7","article-title":"Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes","volume":"72","author":"Shimazu","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2022.105404_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02738621","article-title":"L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors","volume":"10","author":"ThyagaRajan","year":"1999","journal-title":"Endocrine"},{"key":"10.1016\/j.neuint.2022.105404_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-2999(82)90099-1","article-title":"Effects of clorgyline and deprenil on corticosterone levels in rats","volume":"81","author":"Ventura","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105404_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: history, evaluation and usage","volume":"6","author":"Willner","year":"2016","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuint.2022.105404_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.neuint.2022.105404_bib30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0968-0896(01)00002-5","article-title":"Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain","volume":"9","author":"Yoneda","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuint.2022.105404_bib31","doi-asserted-by":"crossref","first-page":"E1110","DOI":"10.1152\/ajpendo.00219.2003","article-title":"Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint","volume":"285","author":"Zelena","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuint.2022.105404_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3892\/ijmm.2013.1450","article-title":"Selegiline rescues gait deficits and the loss of dopaminergic neurons in a subacute MPTP mouse model of Parkinson's disease","volume":"32","author":"Zhao","year":"2013","journal-title":"Int. J. Mol. Med."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:59:05Z","timestamp":1759312745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018622001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"alternative-id":["S0197018622001292"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105404","relation":{},"ISSN":["0197-0186"],"issn-type":[{"type":"print","value":"0197-0186"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic treatment with enhancer drugs modifies the gene expression of selected parameters related to brain plasticity in rats under stress conditions","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105404"}}